| Application no. and date | 09768693.5 (espacenet) (Federated) (European Patent Register), 20090625 | | Patent/reg. no. and date | DK/EP 2307454, 20170118 | | Publication date | 20110413 | | Priority no. and date | US 75697 P, 20080625, US 75692 P, 20080625, US 133212 P, 20080625, US 155041 P, 20090224 | | EP pub. no. and date |
EP 2307454 20110413 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | P066286DK | | Inventor | GUNDE, Tea, Ottostrasse 15
8005 Zürich, CH,
BORRAS, Leonardo, Bundentalstrasse 1
8952 Schlieren, CH,
URECH, David, Widmen 8
8634 Hombrechtikon, CH | | Representative | LARSEN & BIRKEHOLM A/S SKANDINAVISK PATENTBUREAU, Bredgade 3, 3., 1260 København K | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , C07K 16/22 (2006.01) | | Title | Stabile og opløselige antistoffer, som inhiberer VEGF | | Int. application no. | CH2009000220 | | Int. publication no. | WO2009155724 | | Related patent (certificate) | CA 2020 00034 | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
